Sun Pharmaceutical industries share price has declined 4-5% in 2 trading sessions following OAI status determined by the ...
Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...
Regulatory troubles continue for Sun Pharma as the drug manufacturer’s Mumbai unit ... before taking any investment decisions. Advisory Alert: It has come to our attention that certain ...
In two import alerts posted in late March and early April, the FDA said all of Jiangsu Shenli's piston syringes are subject to detention without physical examination. The agency first raised ...
Sun Pharmaceutical Industries witnessed a 3.4% decline in its shares as the US FDA categorized its Dadra facility as 'official action indicated' (OAI), suggesting recommended regulatory or ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
It usually goes without saying that your pharmaceutical production workers need to be gowned and gloved while handling drug materials inside clean rooms. And, at the bare minimum, those workers ...
While the drug is approved for adults in the U.S., the European label covers patients 16 years of age and older. Pfizer bought Velsipity through its $6.7 billion Arena Pharmaceuticals acquisition.
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Royalty Pharma plc (Symbol: RPRX) entered into oversold territory, hitting an RSI reading of ...
Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 ...